Legacy Bridge, LLC Abb Vie Inc. Transaction History

Legacy Bridge, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $65,282 - $78,290	472 New	472 $0
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $1.41 Million - $1.79 Million	-10,222 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $3,222 - $4,077	30 Added 0.29%	10,222 $1.38 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $2,128 - $2,415	20 Added 0.2%	10,192 $1.1 Million
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $44,714 - $49,814	425 Added 4.36%	10,172 $1.15 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $83,476 - $91,897	816 Added 9.14%	9,747 $1.06 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $111,881 - $151,051	1,390 Added 18.43%	8,931 $957,000
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $1,632 - $1,915	-19 Reduced 0.25%	7,541 $661,000
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $31,989 - $42,806	-436 Reduced 5.45%	7,560 $742,000
Q1 2020 Apr 09, 2020	BUY	$64.5 - $97.79 $45,085 - $68,355	699 Added 9.58%	7,996 $609,000
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $101,991 - $127,613	-1,414 Reduced 16.23%	7,297 $646,000
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $39,047 - $46,946	-620 Reduced 6.64%	8,711 $660,000
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $726,418 - $895,869	9,331 New	9,331 $860,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Legacy Bridge, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Bridge, LLC with notifications on news.